chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and medication information provided.  No treatment information provided.          Reporter did not allow further contact
Severe migraine with aura, which I haven?t experienced over the past 7 years. Took 800mg of ibuprofen.  Still in pain at about 24 hour mark from the onset of symptoms
Currently in the intensive care unit: Right MCA thrombotic infarction, cytotoxic cerebral edema. Elevated CK, Microcytic anemia. 3% saline in the emergency department for cerebral edema. Taken emergently to the OR for decompressive right hemicraniectomy. Keppra for seizure prophylaxis. packed red blood cells
Patient called to let us know that about 12 hours after receiving the Moderna vaccine she had stomach upset and felt like vomiting. As she was walking to the bathroom she became very dizzy and fainted . Her husband was home and was able to bring her to . She is okay except for body pain from the fall and a headache. She is going to go to the doctor to get checked just to be on the safe side.
on April 30,2021 I woke up thinking I was having a CVA, the room was spinning and I felt nauseous .  I went to the ER at the regional Hospital.  When admitted the check my vital signs, chest  x-ray, CT brain scan . CVA negative, chest clear, heart rate elevated to 155bpm
2 days after vax pt exp ecchymoses on hands & fingers, low platelets, target cells, low hemoglobin, & low hematocrit.
he had no reaction to the first dose, other than typical reactions like itching at the injection site for a few minutes and then they were fine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE PRURITUS (he had no reaction to the first dose, other than typical reactions like itching at the injection site for a few minutes and then they were fine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetic. Concomitant products included INSULIN for Diabetes.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PRURITUS (he had no reaction to the first dose, other than typical reactions like itching at the injection site for a few minutes and then they were fine). In March 2021, VACCINATION SITE PRURITUS (he had no reaction to the first dose, other than typical reactions like itching at the injection site for a few minutes and then they were fine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient ethnicity reported as (withheld).  Concomitant medication included medication for blood pressure daily. Patient never had any reactions to these medications prior to vaccination  No treatment medication was reported.
Chills for approx 1 hour, fever, and vomited day of vaccine administered and chills day after.
No adverse event; HCP administered a Modena Monovalent vaccine 36 hours after the vial has been punctured.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP administered a Modena Monovalent vaccine 36 hours after the vial has been punctured.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     It was unknown if the patient had other medical condition.     On 24-Dec-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 24-Dec-2022,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP administered a Modena Monovalent vaccine 36 hours after the vial has been punctured.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP administered a Modena Monovalent vaccine 36 hours after the vial has been punctured.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP administered a Modena Monovalent vaccine 36 hours after the vial has been punctured.).    No concomitant medications were reported. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Monovalent administered after 12 hours, 36 after the vial has been punctured. It was unknown if the patient undergone tests. No treatment information was reported.
Chills Uncontrollable shaking High fever (103.6F max) Skin color changing
After a few minutes from vaccination, I got lightheaded and a weird mouth feel/taste. I also felt a tingling or weird sensation spread from my arm to face and then throughout body. It felt like pressure and a tension headache with a weird not quite prickling but not quite tingling. Everything got very tight and felt like a body headache. As lightheaded increased in waves mouth feel also was more, then lightheadedness and mouth started to slowly subside. During this time I drank water and reclined in my car. I also felt heavy and weak, which  continued for longer than other symptoms. Overall it felt like I had some reaction to the vaccine shortly after and within an hour or even half hour it had levelled and started to reduce. By the next day I felt fine except for normal vaccine immune responses (headache, fatigue, sore arm).
Two hours after the shot the patient patient had overall body chills that stayed with her for several hours.; Right arm injection site was sore; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Two hours after the shot the patient patient had overall body chills that stayed with her for several hours.) and VACCINATION SITE PAIN (Right arm injection site was sore) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CHILLS (Two hours after the shot the patient patient had overall body chills that stayed with her for several hours.). 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Right arm injection site was sore). On 02-Feb-2021, CHILLS (Two hours after the shot the patient patient had overall body chills that stayed with her for several hours.) had resolved. At the time of the report, VACCINATION SITE PAIN (Right arm injection site was sore) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2022-507441 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2022: Follow up received contains non-significant information: Date of administration of first dose was amended.
This case was reported by a pharmacist via call center representative and described the occurrence of feeling unwell in a 77-year-old female patient who received SHINGRIX (batch number A2JL7, expiry date 22nd March 2021) for prophylaxis. On 2nd October 2018 10:15, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 2nd October 2018, less than a day after receiving SHINGRIX, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown. It was unknown if the reporter considered the feeling unwell to be related to SHINGRIX. Additional details were provided as follows: The reporter stated that, the patient did not feel good, kind of sick feeling after receiving SHINGRIX. This case has been linked to the case US2018183676, reported by same reporter.
Client initially vaccinated for COVID-19 with Moderna on 04/21/2021(014C21A) and 05/19/2021 (027C21A). 10/15/2021, client vaccinated for 3rd dose with Pfizer (FF2593).
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 80-year-old patient of unknown gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date in 2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dose, dose # and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported.  The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
Client was vaccinated with Pfizer vaccines x 2 in February, 2021.  Client not sure of dates.  Attended a clinic for both vaccines.  Client tested positive for Covid on 8/20/2021 with symptoms starting on 8/11.  chills, runny nose, cough, fever, headache.  Symptoms resolved as of 8/23.  Reported as breakthrough Covid case in fully vaccinated person.
large erythemetous area at the site of injection, painful, occurred within 8-12 hrs after injection no treatment
Unconsolable screaming on and off for 4 days. Not eating.Anti social.  Does not seem herself at all. I am unsure at this point how bad it is going to get. I will no longer vaccinate my child. The last DTap she had similar symtoms but only lasted 3 days
Blisters; Rash lead to weeping; Rash on scalp, right ear, right side of neck, chest, back/ Rash lead to very painful sores; Shingles; Information has been downloaded from Agency (US-CHIRONMA-PHHY2015US001716).  Information has been received from an other healthcare professional referring to a 60 years old male patient. The patient's medical history and concurrent condition was not provided. The patient's concomitant medication included escitalopram oxalate (LEXAPRO), pravastatin, minerals (unspecified) (+) vitamins (unspecified) (CENTRUM), ubiquinones (unspecified) and selenium (unspecified).     On 01-OCT-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (1 dosage form; strength, lot # and expiration date were unknown) intramuscularly for immunisation. On the same day, the patient was also vaccinated with influenza virus vaccine (unspecified) (1 dosage form (DF); strength, lot # and expiration date were unknown) intramuscularly for immunisation.  On 08-OCT-2014, 7 days after onset of therapy, the patient experienced blisters, rash lead to weeping, rash on scalp, right ear, right side of neck, chest, back/ rash lead to very painful sores and shingles. The outcome of all the events was unknown. The causality between all the events and vaccinated with zoster vaccine live (ZOSTAVAX) was not provided. The causality between all the events and influenza virus vaccine (unspecified) was assessed as suspected by the reporter.  The events of blisters, rash lead to weeping, rash on scalp, right ear, right side of neck, chest, back/ rash lead to very painful sores and shingles were considered to be medically significant by the reporter.
My wife received the seasonal flu shot and the shingles vaccine, on the same day. The type that will require a booster in about two months. 12 hours later she began experiencing fever, 100.2/F, fatigue/night sweats/ loss of appetite/dizziness. Going on for three days.
I had throat irritation, sinus irritation and nasal congestion that continued for approximately ten days. I had drainage into my throat which created a cough.
swelling and tenderness in lower right leg / vasculitis; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the right arm) on 03Apr2021 10:15 (at the age of 34-years-old) as 1st dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included alprazolam (XANAX) and propranolol both taken for an unspecified indication, start and stop date were not reported.  The patient previously took PERCOCET and experienced mild allergy. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient experienced swelling and tenderness in lower right leg / vasculitis on 06Apr2021 15:00. It was reported that 3 days after vaccination the patient experienced swelling and tenderness in lower right leg and was initially misdiagnosed as infection. After symptoms persisted for 1.5 weeks and antibiotics had no effect, it was diagnosed as vasculitis. No rheumatological issues in blood test or blood clot. PCP determined likely an immune response to the vaccine. The adverse event resulted in emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event included antibiotics and antiinflamttories. Since the vaccination the patient has not been tested for COVID-19. The outcome of the event was recovering.
Localized itching since day of vaccine. 3 days ago area became red, slightly swollen. Patient seen by PCP, prescribed doxycycline twice daily for 10 days.
Vaginitis; Cough; MUCUS IN CHEST; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL INFECTION (Vaginitis), COUGH (Cough) and SECRETION DISCHARGE (MUCUS IN CHEST) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced VAGINAL INFECTION (Vaginitis), COUGH (Cough) and SECRETION DISCHARGE (MUCUS IN CHEST). At the time of the report, VAGINAL INFECTION (Vaginitis) was resolving and COUGH (Cough) and SECRETION DISCHARGE (MUCUS IN CHEST) outcome was unknown.            Concomitant medication was not reported.  On an unknown date, patient experienced inflammation in vagina area and buttock area felt like had homolids/there was itching and burning, bad cough and mucus in chest. Treatment details were not reported.  It was unknown if patient was enrolled in a COVID-19 vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
About 12 hrs later, intense shaking/fever began..   Chills, then fever began at 99.6.  Muscle/joint aches/pain, weakness.  Tiny headache.  Into the next day fever fluctuated between 99.6-100.7.  Painful to move.  Feel rotten.  Still having symptoms 30 hrs later.
Dead arm for the first 2 days. Then nothing, until 10 days after the injection, when a raised red rash about 5 inches in diameter appeared on my upper arm at the injection site. A little swollen and itchy, but fine. It lasted about 5 days.
Moderna COVID-19 Vaccine EUA     SIDE EFFECTS EXPERIENCED: Immediate burning at injection site  Within an hour of injection and continuing for 24/36 hours:  redness/rash for about 3 inches around injection site, mild headache,  mild stomach upset, sore arm and soreness extended to back & under arm, general malaise. At 12 Hours plus:  Rash on chest that only lasted for a few hours At 36 hour point:  nausea, arm still sore
Patient is complaining of pain for 2 weeks. No heat or swelling. Complaining the pain is in the joint.
Information has been received on 17-JAN-2017 from a nurse regarding a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 17-JAN-2017 the patient was inadvertently vaccinated with GARDASIL 9 lot # M028323, expiration 26-SEP-2017 unknown route for prophylaxis while 4 weeks 3 days pregnant at the time of the administration. No adverse effects reported. No further information was reported. The LMP and EDD are not known. The outcome of exposure during pregnancy and no adverse event is unknown. Additional information has been requested.
Moderna COVID-19 Vaccine EAU Right arm at and near the injection site became  red,hot and knotty to the touch.  It  started a week after the shot was given.  The day after symptoms started,  the redness has expanded.  I  don't know the outcome yet.
LPN 8/14/2018 11:49:11 AM greater temp of 101.2 (rectal); resolved to 99.6 (rectal) after TYLENOL given. Having explosive diarrhea - has gone through 3 outfits all ready today. Extremely lethargic (has no energy; just laying on mom instead of playing with her toys); very restless; was up every 45 minutes fussing and crying. Not interested in nursing -- only taking 2 oz q 4 hours; mom is offering 2 mL TYLENOL. Injection sites are a little swollen (similar to previous injections) LPN 8/15/2018 11:10:28 AM > mom states that she is doing much better: mom states that child's fever broke at 0300; finally slept from 0330-0830. States that she finally took 3 oz bottle this AM; mom is still offering 2 oz PEDIALYTE every couple hours; child has voided x 1 so far today and has not had any dirty diapers yet today (stooled x5 yesterday). LPN 8/15/2018 12:21:38 PM > mom states that child was noted to have redness around the injection site at 2200 and was noted to have a golf ball sized raised spot on right leg. Mom states that swelling resolves when TYLENOL is given and applies ice. States that swelling returns but no longer red -- appt scheduled for 1000 on 8/16, LPN 8/16/2018 10:26:43 AM > message left at 1343 on 8/15 retrieved from voicemail at his time: mom just noticed what looks like a mosquito bite right on inside of thigh (mom is allergic to mosquito bites so thinks this is child's issue too); applied HCC and looks drastically better so doesn't think that needs to be seen. Still having a little diarrhea but more solid than before.
patient stated to boyfriend was seeing black spots so sat down and then lost consciousness.   boyfriend said she was shaking for a bit. and then came back around.  patient lost all color to face and was sweaty.   black spots in vision continued for 10 minutes tingling in fingers continued for 10 minutes.  medic came and checked her out and she walked out about a half hour after the shot
Got shot 11:00 AM 10/20. 11:00 PM 10/20 total body myalgia 10/21 called off work -> severe body myalgia. Took OTC ibuprofen. 10/22 felt little better. Still took off work. 10/23 felt better still and went to work. Now just has swelling at injection site.
Got the vaccine, and about 24 hours later she started to feel an ache in her front left tooth.  She was wondering if this was due to the vaccine or not.  She was unable to lift her arm as well.  In a couple of hours it was real sore and she kept hitting it with her tooth.  Her upper gum was then tender and could not touch it.  She then could not chew on the front left tooth, and even hurt with touching of her tongue.  As the night progressed more teeth were tender, and the lip was also more tender.  She started to get a headache and then all of her joints were starting to hurt.  The next morning, Friday morning she had no energy at all, just felt terrible.  Her face was now swollen, as well as her upper lip.  That night it was getting worse adn worse and her gums were so itchy and all the teeth on the left side felt loose.  It then reached her jaw and then the swelling went to her eye.  She called her PCP, and put on antibiotics, to take a antihystamine and a steroid.  Told her to go to the ER if it did not gete better.  It was horrible by Monday morning, she went to UC and had an abscess in her tooth.  They put her on penicillin, told her not to take the other antibiotics.  By Tuesday morning the swelling had gone down, and the swelling in the gums were also gone, and the teeth were also better.  The abscess was also feeling better.  She had no issues with her gums and teeth prior to this.  By the time she finished the penicillin she was fine.  She went to the dentist and they could not find anything wrong with her, and informed her that it was proof that the vaccine was doing it's job.
Patient fully vaccinated (Moderna): 1/27/21, 2/24/21  Patient tested COVID positive while hospitalized on 2/10/22
Sore arm; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PAIN (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and PAIN (Body ache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and PAIN (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Contact details updated